Apollomics

Index
Globenewswire

Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation

Globenewswire

Apollomics, Inc. Company Operational Continuity Update

Globenewswire

Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia